Scientific Advisory BoardOur Vision, utilize the science of Pharma and Biotechnology to become a leader in revolutionizing the treatment of patients with cancer, antigen and immunological disorders.  Prof. J.R.(Camille) Falck, PhDProfessor & Robert A. Welch Distinguished Chair in Chemistry, UT Southwestern Medical Center, Dallas.He was the first to prepare all four EETs, to identify EETs in human samples, to complete stereoselective chemical syntheses of all primary CYP P450 metabolites, to introduce isozyme selective inhibitors of ω-hydroxylase and epoxygenase, to characterize the EET receptor pharmacologically, and he is one of the foremost experts in the application of synthetic and Medicinal chemistry to eicosanoids, the metabolites of arachidonic acid. 
Ken Payie, PhDBusiness AdvisorKen has designed and directed drug development programs through outsourcing to Asia, Europe and North American vendors, and dramatically reduced costs to develop assets without compromising Quality.
Dr.Ken has developed a number of large and small molecule CM&C programs in the Candidate Identification to Phase II space for both large pharma and small drug discovery companies. 
Prof. David Krupadanam, PhDProfessor & Dean Chemistry Research Center Osmania University, HyderabadProf. David, work involves discovery and development of new synthetic methods and their application to biologically active systems and new reaction cascade development and their application to the total synthesis of complex natural products. His work has been recognized by 32 major prizes and awards in the top five percent of Professors by UGC over the past 30 years.
|
Latest News & Events
|
